Zhitong Finance App News, Zhaoyan New Pharmaceutical Source (06127.HK) issued an announcement. As of the disclosure date of this announcement, Zhou Zhiwen, one of the actual controllers of Beijing Zhaoyan New Drug Research Center Co., Ltd. (hereinafter referred to as the “Company”), held 74,725,981 shares of the company's total share capital, accounting for 9.9704% of the company's total share capital. The shares he held came from pre-launch restricted shares and additional shares from the company's capital reserve fund. Zhou Zhiwen plans to reduce his holdings by no more than 14.98 million shares through centralized bidding or bulk transactions at the Shanghai Stock Exchange within 3 months after the announcement of this holdings reduction plan, not more than 20.0466% of the shares he holds and no more than 1.99873% of the company's total share capital within 3 months after the announcement of this holdings reduction plan.

Zhitong Finance App News, Zhaoyan New Pharmaceutical Source (06127.HK) issued an announcement. As of the disclosure date of this announcement, Zhou Zhiwen, one of the actual controllers of Beijing Zhaoyan New Drug Research Center Co., Ltd. (hereinafter referred to as the “Company”), held 74,725,981 shares of the company's total share capital, accounting for 9.9704% of the company's total share capital. The shares he held came from pre-launch restricted shares and additional shares from the company's capital reserve fund. Zhou Zhiwen plans to reduce his holdings by no more than 14.98 million shares through centralized bidding or bulk transactions at the Shanghai Stock Exchange within 3 months after the announcement of this holdings reduction plan, not more than 20.0466% of the shares he holds and no more than 1.99873% of the company's total share capital within 3 months after the announcement of this holdings reduction plan.